GlassScriptPhysician profile
Anna R Jensen
NPI 1811717218
$314.92
in general payments reported to CMS, 2019-2025
16 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $37.84 | 2025 | |
| Calliditas Therapeutics US INC. | $32.87 | 2025 | Tarpeyo |
| Medtronic, INC. | $24.40 | 2025 | Inceptiv |
| Electromed, INC. | $22.06 | 2025 | Smartvest |
| Phathom Pharmaceuticals, INC. | $20.07 | 2025 | Voquezna |
| Dexcom, INC. | $19.34 | 2025 | Dexcom G6 Transmitter |
| Radius Health, INC. | $18.66 | 2025 | Tymlos |
| Madrigal Pharmaceuticals | $16.41 | 2025 | Rezdiffra |
| Exact Sciences Corporation | $16.28 | 2025 | Cologuard Collection Kit |
| Actelion Pharmaceuticals US, INC. | $16.26 | 2025 | Uptravi, Opsumit |
| Amgen INC. | $15.94 | 2025 | Otezla, Repatha |
| Aimmune Therapeutics, INC. | $15.62 | 2025 | Zenpep |
| Apellis Pharmaceuticals, INC. | $15.57 | 2025 | Empaveli |
| Collegium Pharmaceutical, INC. | $15.00 | 2025 | Belbuca |
| Astrazeneca Pharmaceuticals LP | $14.30 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $14.30 | 2025 | Vest Therapy Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.